GlobalData on MSN
Podcast: The FDA’s emerging aversion to advisory committees
The FDA’s growing aversion to advisory committees stokes concerns around the transparency and scientific grounding of ...
The FDA has terminated its Arthritis Advisory Committee, citing the panel’s infrequent meetings and the cost of keeping it ...
I don’t think they’re needed,” said George Tidmarsh, head of the FDA’s Center for Drug Evaluation and Research.
On Tuesday, a U.S. Food and Drug Administration advisory committee voted unanimously that the oral formulation of a very common nasal decongestant, phenylephrine, is not effective. The decision could ...
Before Exelexis’ Cabometyx can pass muster with the FDA in its hopeful neuroendocrine tumors indication next April, it will have to first face the agency’s Oncologic Drugs Advisory Committee (ODAC) in ...
FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment
Amgen (NASDAQ: AMGN) announced today that the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) and the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration ...
In her role, Bumpus will serve as a part-time strategic advisor to Charles River, a spokesperson for the company told Fierce ...
FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results